Literature DB >> 33797774

Making the most of high-dimensional cytometry data.

Felix Md Marsh-Wakefield1,2,3, Andrew J Mitchell4, Samuel E Norton5,6, Thomas Myles Ashhurst2,7,8, Julia Kh Leman6, Joanna M Roberts9, Jessica E Harte6, Helen M McGuire2,8,10, Roslyn A Kemp6.   

Abstract

High-dimensional cytometry represents an exciting new era of immunology research, enabling the discovery of new cells and prediction of patient responses to therapy. A plethora of analysis and visualization tools and programs are now available for both new and experienced users; however, the transition from low- to high-dimensional cytometry requires a change in the way users think about experimental design and data analysis. Data from high-dimensional cytometry experiments are often underutilized, because of both the size of the data and the number of possible combinations of markers, as well as to a lack of understanding of the processes required to generate meaningful data. In this article, we explain the concepts behind designing high-dimensional cytometry experiments and provide considerations for new and experienced users to design and carry out high-dimensional experiments to maximize quality data collection.
© 2021 The Authors. Immunology & Cell Biology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.

Entities:  

Keywords:  Analysis; experimental design; flow cytometry; high-dimensional data; mass cytometry

Year:  2021        PMID: 33797774     DOI: 10.1111/imcb.12456

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  4 in total

1.  How to Prepare Spectral Flow Cytometry Datasets for High Dimensional Data Analysis: A Practical Workflow.

Authors:  Hannah den Braanker; Margot Bongenaar; Erik Lubberts
Journal:  Front Immunol       Date:  2021-11-19       Impact factor: 7.561

2.  CyTOF mass cytometry analysis of human memory CD4+ T cells and memory B cells.

Authors:  Lisa J Ioannidis; Andrew J Mitchell; Tian Zheng; Diana S Hansen
Journal:  STAR Protoc       Date:  2022-03-30

3.  Simplified mass cytometry protocol for in-plate staining, barcoding, and cryopreservation of human PBMC samples in clinical trials.

Authors:  Charlotte Abrecht; Margaret Hallisey; Jenna Dennis; Matthew Nazzaro; Martha Brainard; Emma Hathaway; Abigail N Schork; F Stephen Hodi; Mariano Severgnini; Joanna Baginska
Journal:  STAR Protoc       Date:  2022-05-05

4.  Peripheral B-cell dysregulation is associated with relapse after long-term quiescence in patients with multiple sclerosis.

Authors:  Felix Marsh-Wakefield; Pierre Juillard; Thomas M Ashhurst; Annette Juillard; Diana Shinko; Givanna H Putri; Mark N Read; Helen M McGuire; Scott N Byrne; Simon Hawke; Georges E Grau
Journal:  Immunol Cell Biol       Date:  2022-05-12       Impact factor: 5.853

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.